Yum! Brands Beats Earnings Expectations. no Word on Cyclosporiasis Outbreak.

Dow Jones
Jul 30

Yum! Brands surpassed second-quarter earnings expectations as Taco Bell same-store sales grew 7%. However, much of the focus around the company has been on the cyclosporiasis outbreak that has been linked to lettuce served at Taco Bell.

The fast-food giant on Thursday posted adjusted earnings of $1.62 a share, up from $1.44 a year ago and just above Wall Street expectations of $1.58. Revenue grew 12% to $2.17 billion, slightly missing the analyst consensus call for $2.18 billion, according to FactSet.

Same-store sales at Taco Bell grew 7% and system sales at the chain increased 9% from last year. Worldwide system sales grew 5% in the quarter. There was no update in the earnings report around the cyclosporiasis outbreak.

The Food and Drug Administration on July 16 announced an investigation into the outbreak linked to lettuce served by Taco Bell. The outbreak has put pressure on Taco Bell daily traffic and on Yum! Brands stock. Shares have fallen 5% this month as of Wednesday's closing bell.

As of July 24, the cyclosporiasis outbreak, tied to iceberg lettuce sources from central Mexico, has resulted in 1,947 people being infected with at least 98 hospitalizations, according to the FDA and Centers for Disease Control and Prevention data. The data didn't reveal how many cases were suspected from Taco Bell.

The stock rose slightly in premarket trading Thursday after ending Wednesday up 1%.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10